Evidence map›Paper›PMID 42422260›Full record

ArticleIBRO neuroscience reports2026

The effects of

Masoume Akhbari, Fatemeh Babaei, Ava Navidi-Moghaddam, Shiva Ghafghazi, Fatemeh Khodabandehloo, Mohammad Reza Sarookhani, Leila Dargahi, Ghazaleh Mohammadi, Marjan Nassiri-Asl

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IBRO neuroscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Masoume AkhbariDepartment of Molecular Medicine, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Fatemeh BabaeiNeuroscience Research Center, Institute of Neuroscience and Cognition, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ava Navidi-MoghaddamSchool of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shiva GhafghaziDepartment of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Fatemeh KhodabandehlooDepartment of Genetics and Advanced Medical Technology, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran.
Mohammad Reza SarookhaniCellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran.
Leila DargahiNeuroscience Research Center, Institute of Neuroscience and Cognition, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ghazaleh MohammadiDepartment of Molecular Medicine, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Marjan Nassiri-AslNeuroscience Research Center, Institute of Neuroscience and Cognition, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Interleukin-1βLipopolysaccharideMemoryNeuroinflammatory signalingNuclear factor kappa BSaccharomyces boulardii

Identifiers

PMID42422260
PMCPMC13342975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.